Literature DB >> 21807824

Medicaid cutbacks and state psychiatric hospitalization of patients with schizophrenia.

Bentson H McFarland1, Jon C Collins.   

Abstract

OBJECTIVE: Given financial difficulties precipitated by the flagging national economy, state policy makers are interested in the impact of Medicaid cutbacks on individuals with schizophrenia. Starting in 2003, the Oregon legislature eliminated all Medicaid coverage for large numbers of people, including many with schizophrenia. The objective of this project was to examine state psychiatric hospital utilization among persons with schizophrenia who maintained or lost Medicaid coverage.
METHODS: This longitudinal cohort study examined Oregon schizophrenia patients who had used Medicaid mental health services before the state's massive Medicaid reductions. Data were obtained from the state mental health, Medicaid, and vital statistics agencies. The outcome measures were involuntary psychiatric admissions to general hospitals and to state psychiatric hospitals, respectively. There were three cohorts, which comprised those who lost Medicaid coverage in calendar year 2003 (N=435), those who lost Medicaid coverage in 2004 (N=187), and those who maintained Medicaid coverage throughout study years 2002-2004 (N=3,427).
RESULTS: Cohort members were on average 43 years old, and the sample was 42% female and 88% white. Analyses controlling for age, gender, race-ethnicity, Medicaid eligibility, and Medicare coverage showed that persons who maintained Medicaid coverage had little change in state psychiatric hospitalization, whereas utilization increased markedly over time for those who lost Medicaid coverage (p<.003). There were few differences in utilization of general hospital psychiatric units. Loss of Medicaid coverage generally preceded hospitalization.
CONCLUSIONS: State policies designed to decrease Medicaid enrollment may have led to increased use of state psychiatric hospitals by former Medicaid enrollees with schizophrenia.

Entities:  

Mesh:

Year:  2011        PMID: 21807824     DOI: 10.1176/ps.62.8.pss6208_0871

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  4 in total

Review 1.  EPA guidance on mental health and economic crises in Europe.

Authors:  M Martin-Carrasco; S Evans-Lacko; G Dom; N G Christodoulou; J Samochowiec; E González-Fraile; P Bienkowski; M Gómez-Beneyto; M J H Dos Santos; D Wasserman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-02-13       Impact factor: 5.270

2.  Discontinuity of Medicaid Coverage: Impact on Cost and Utilization Among Adult Medicaid Beneficiaries With Major Depression.

Authors:  Xu Ji; Adam S Wilk; Benjamin G Druss; Cathy Lally; Janet R Cummings
Journal:  Med Care       Date:  2017-08       Impact factor: 2.983

3.  Length of psychiatric hospitalization is correlated with CYP2D6 functional status in inpatients with major depressive disorder.

Authors:  Gualberto Ruaño; Bonnie L Szarek; David Villagra; Krystyna Gorowski; Mohan Kocherla; Richard L Seip; John W Goethe; Harold I Schwartz
Journal:  Biomark Med       Date:  2013-06       Impact factor: 2.851

4.  Impact of oral antipsychotic medication adherence on healthcare resource utilization among schizophrenia patients with Medicare coverage.

Authors:  Steve Offord; Jay Lin; Bruce Wong; Dario Mirski; Ross A Baker
Journal:  Community Ment Health J       Date:  2013-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.